Inventor · disambiguated record
Jessica Elversson
Also filed as: Elversson Jessica
16 granted patents·4 pending applications·96 citations·filing 2017–2024
93Inventor score
Files withALBIREO AB20
Top patents by PatentIndex Score
20 records- 0197US10975046B2Crystal modifications of odevixibatALBIREO AB·Filed 2019·Granted Apr 13, 2021·22 cites·20 claims
- 0296US11801226B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2020·Granted Oct 31, 2023·11 cites·15 claims
- 0396US11365182B2Crystal modifications of odevixibatALBIREO AB·Filed 2020·Granted Jun 21, 2022·10 cites·18 claims
- 0496US10786529B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2017·Granted Sep 29, 2020·12 cites·25 claims
- 0595US12091394B2Crystal modifications of odevixibatALBIREO AB·Filed 2022·Granted Sep 17, 2024·4 cites·27 claims
- 0695US11802115B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2019·Granted Oct 31, 2023·11 cites·16 claims
- 0793US10441605B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2017·Granted Oct 15, 2019·6 cites·22 claims
- 0893US10441604B2Cholestyramine pellets and methods for preparation thereofALBIREO AB·Filed 2017·Granted Oct 15, 2019·6 cites·18 claims
- 0991US11007142B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted May 18, 2021·5 cites·21 claims
- 1091US10610543B2Cholestyramine pellets and methods for preparation thereofALBIREO AB·Filed 2018·Granted Apr 7, 2020·4 cites·19 claims
- 1188US10864228B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted Dec 15, 2020·2 cites·30 claims
- 1288US10799527B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted Oct 13, 2020·2 cites·30 claims
- 1385US2025019354A1Crystal Modifications of OdevixibatALBIREO AB·Filed 2024·Application pending·0 cites
- 1482US12508234B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2023·Granted Dec 30, 2025·0 cites·20 claims
- 1580US10722457B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted Jul 28, 2020·1 cites·21 claims
- 1677US2024130976A1Pharmaceutical Formulation of OdevixibatALBIREO AB·Filed 2023·Application pending·0 cites
- 1769US10758563B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted Sep 1, 2020·0 cites·27 claims
- 1869US10493096B2Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2018·Granted Dec 3, 2019·0 cites·22 claims
- 1953US2020046757A1Cholestyramine pellets, oral cholestyramine formulations, and uses thereofALBIREO AB·Filed 2019·Application pending·0 cites
- 2053US2020046758A1Oral cholestyramine formulation and use thereofALBIREO AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jessica Elversson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →